Dr. Cassianne Robinson-Cohen's research investigates the genetic and molecular determinants of kidney disease risk, resilience, and progression. She integrates genomics with deep clinical phenotyping in large biobanks to identify risk factors, biological pathways, and therapeutic targets that explain why some individuals develop kidney disease while others remain protected.